introduct
sever
trauma
repres
lead
caus
mortal
worldwid
death
occur
within
first
hour
trauma
occur
later
mainli
due
healthcareassoci
infect
includ
ventilatorassoci
pneumonia
vap
prevent
underinfl
tracheal
cuff
recommend
reduc
microaspir
play
major
role
pathogenesi
vap
automat
devic
facilit
regul
tracheal
cuff
pressur
implement
potenti
reduc
vap
object
work
determin
whether
continu
regul
tracheal
cuff
pressur
use
pneumat
devic
reduc
incid
vap
compar
intermitt
control
sever
trauma
patient
method
analysi
multicentr
randomis
control
openlabel
trial
includ
patient
suffer
sever
trauma
admit
within
first
hour
requir
invas
mechan
ventil
longer
hour
tracheal
cuff
pressur
monitor
either
everi
hour
control
group
continu
use
pneumat
devic
intervent
group
primari
end
point
proport
patient
develop
vap
intens
care
unit
icu
day
secondari
end
point
includ
proport
patient
develop
vap
icu
earli
day
late
day
vap
time
first
vap
diagnosi
number
ventilatorfre
day
antibioticfre
day
length
stay
icu
proport
patient
ventilatorassoci
event
die
icu
stay
ethic
dissemin
protocol
approv
ethic
committe
poitier
univers
hospit
carri
accord
principl
declar
helsinki
good
clinic
practic
guidelin
result
studi
dissemin
present
scientif
confer
public
peerreview
journal
trial
registr
clinic
trial
introduct
background
rational
sever
trauma
repres
lead
caus
mortal
worldwid
third
highest
caus
death
franc
behind
cardiovascular
diseas
cancer
death
follow
trauma
occur
per
inhabit
per
year
franc
repres
strength
limit
studi
studi
conduct
multicentr
randomis
control
openlabel
trial
adequ
power
determin
whether
continu
regul
tracheal
cuff
pressur
use
pneumat
devic
reduc
incid
ventilatorassoci
pneumonia
first
larg
studi
topic
potenti
chang
intern
recommend
ventilationassoci
pneumonia
prevent
studi
benefit
includ
reduc
durat
mechan
ventil
stay
intens
care
unit
improv
patient
prognosi
reduct
antibiot
use
limit
due
lack
mask
relat
natur
intervent
limit
mask
end
point
assess
open
access
close
death
death
occur
within
first
hour
trauma
directli
relat
trauma
death
occur
later
mainli
due
healthcareassoci
infect
hai
patient
present
sever
trauma
develop
least
one
hai
stay
neurolog
disord
recours
mechan
ventil
earli
posttraumat
immun
suppress
may
explain
elev
incid
hai
particularli
ventilatorassoci
pneumonia
vap
mainli
occur
first
week
follow
trauma
vap
repres
predomin
hai
sever
trauma
patient
mean
incid
may
even
exceed
seri
follow
cathet
infect
bacteraemia
hai
account
heighten
morbid
mortal
longer
stay
intens
care
unit
icu
increas
treatment
cost
franc
addit
cost
estim
million
per
year
infect
also
requir
high
use
antibiot
vap
alon
make
half
antibiot
treatment
prescrib
icu
given
select
pressur
induc
antibiot
therapi
favour
appear
bacteri
resist
presenc
foreign
materi
tracheal
tube
stomach
tube
facilit
colonis
upper
airway
digest
tract
endogen
exogen
microorgan
tracheal
contamin
origin
bacteri
aspir
result
passag
secret
around
cuff
tracheal
tube
accumul
tracheal
cuff
rare
vap
aris
contamin
stagnant
water
ventil
circuit
use
colonis
aerosol
contamin
contigu
site
almost
exclus
pleural
caviti
prevent
measur
vap
enhanc
knowledg
pathophysiolog
vap
led
develop
effect
prevent
strategi
vap
prevent
measur
recommend
french
consensu
confer
nosocomi
infect
prevent
state
orotrach
rout
use
tracheal
intub
instead
nasal
rout
tracheal
cuff
pressur
maintain
cm
h
also
recommend
use
sedationanalgesia
algorithm
facilit
earli
wean
ventil
avoid
unplan
extub
prioritis
use
noninvas
ventil
follow
recognis
indic
place
patient
semirecumb
posit
regularli
decontamin
nasal
oropharyng
caviti
suitabl
mouth
care
start
enter
nutrit
earli
possibl
combin
system
antibiot
therapi
select
digest
decontamin
may
recommend
implement
requir
specif
modal
choic
dose
durat
select
digest
decontamin
antibiot
therapi
target
popul
maintain
suffici
level
pressur
tracheal
tube
cuff
critic
import
pressur
low
patient
risk
inhal
accumul
subglott
secret
oropharynx
known
play
major
role
vap
incid
altern
pressur
high
risk
ischaemia
tracheal
mucosa
remov
tracheal
oedema
later
tracheal
stenosi
therefor
regular
monitor
tracheal
cuff
pressur
recommend
optim
monitor
frequenc
yet
clearli
determin
underinfl
andor
overinfl
tracheal
cuff
often
occur
ventil
patient
intermitt
manual
control
tracheal
cuff
pressur
use
manomet
wellknown
sourc
morbid
mortal
recent
publish
data
favour
use
automat
devic
abl
continu
regul
tracheal
cuff
pressur
even
though
sever
learn
societi
recommend
implement
purpos
vap
prevent
ventil
patient
recent
find
literatur
tend
favour
use
howev
studi
sever
limit
monocentr
studi
includ
rel
small
number
particip
rare
includ
sever
trauma
patient
even
though
greatest
risk
vap
studi
systemat
appli
recommend
vap
prevent
measur
contest
choic
main
studi
end
point
two
method
continu
regul
tracheal
cuff
pressur
avail
pneumat
electron
publish
studi
favour
first
due
better
reactiv
fewer
period
insuffici
excess
tracheal
cuff
pressur
consequ
reduc
risk
microb
inhal
tracheal
injuri
addit
low
acquisit
cost
eas
use
electr
suppli
requir
object
object
studi
determin
whether
continu
regul
tracheal
cuff
pressur
use
mechan
pneumat
regul
devic
nosten
leve
pari
superior
intermitt
control
tracheal
cuff
pressur
reduc
incid
vap
sever
trauma
patient
receiv
recommend
method
vap
prevent
individu
level
benefit
expect
includ
shorter
durat
mechan
ventil
stay
icu
well
improv
patient
outcom
collect
level
addit
reduc
cost
hospit
stay
number
day
antibiot
also
declin
along
select
pressur
perpetu
emerg
multidrugresist
bacteria
agat
trial
multicentr
randomis
control
openlabel
clinic
trial
two
parallel
group
primari
end
point
proport
patient
develop
vap
icu
day
randomis
carri
secur
webbas
randomis
system
stratifi
centr
sever
patient
unconsci
time
inclus
glasgow
coma
scale
lower
higher
equal
patient
consid
candid
inclus
studi
meet
inclus
criteria
none
exclus
criteria
box
patient
suffer
sever
trauma
admit
within
first
hour
requir
invas
mechan
ventil
expect
last
longer
hour
includ
studi
case
patient
inclus
take
place
soon
possibl
icu
admiss
hour
follow
trauma
andor
hour
follow
oral
intub
trachea
pregnant
lactat
women
includ
studi
materi
use
present
specif
risk
teratogen
patient
includ
studi
randomis
one
two
treatment
group
base
method
use
monitor
tracheal
cuff
pressur
benefit
daili
monitor
throughout
hospit
stay
icu
follow
criteria
appli
patient
control
throughout
durat
studi
monitor
tracheal
cuff
pressur
tracheal
tube
either
everi
hour
control
group
continu
intervent
group
use
pneumat
devic
nosten
object
maintain
pressur
cm
h
implement
ident
sedat
wean
protocol
centr
implement
lung
protect
ventil
strategi
maintain
tidal
volum
mlkg
ideal
bodi
weight
posit
endexpiratori
pressur
cm
h
respiratori
rate
set
achiev
normocapnia
option
moder
hypocapnia
accord
protocol
observ
unit
extub
consid
soon
patient
glasgow
coma
scale
patient
cough
spontan
secondari
bronchial
aspir
level
pressur
support
cm
h
spontan
ventil
tpiec
f
lower
toler
patient
least
min
systemat
chang
respir
circuit
preferenti
use
heat
humid
exchang
filter
chang
soil
systemat
applic
bed
inclin
least
monitor
everi
hour
hand
wash
hydroalcohol
friction
prior
treatment
follow
isol
measur
mouth
care
everi
hour
accord
protocol
observ
unit
tracheal
aspir
carri
use
steril
equip
perform
requir
preferenti
oral
insert
feed
tube
start
enter
feed
soon
possibl
systemat
applic
glucos
monitor
protocol
patient
blood
sugar
level
measur
everi
hour
object
maintain
glucos
level
mmoll
prophylact
antibiot
treatment
limit
hour
fractur
oper
within
first
hour
cur
antibiot
therapi
reserv
infect
bacteri
origin
document
probabl
case
antiinfecti
measur
insuffici
accord
recommend
offici
french
health
author
proper
use
antibiot
adequ
dosag
regimen
method
antibiot
administr
provid
ensur
optim
concentr
site
infect
recours
serum
assay
use
whenev
possibl
avoid
underdos
common
caus
failur
well
avoid
overdos
lead
iatrogen
patholog
narrowspectrum
antibiot
prefer
case
sever
infect
antibiot
treatment
start
soon
possibl
follow
diagnost
microbiolog
sampl
start
later
first
hour
case
septic
shock
durat
vap
treatment
limit
week
except
case
nonfer
gramneg
bacteri
infect
antibiot
therapi
continu
week
reduc
risk
recurr
antibiot
associ
strictli
limit
precis
defin
attempt
detect
vap
sign
perform
daili
basi
patient
mechan
ventil
accord
definit
establish
at
box
thorac
xray
aim
detect
vap
carri
within
hour
whenev
least
two
follow
clinic
sign
vap
observ
clinic
examin
fever
hypothermia
purul
endotrach
secret
either
hyperleucocytosi
leucopenia
whenev
patient
meet
clinic
radiolog
criteria
day
vap
suspect
modifi
clinic
pulmonari
infect
score
calcul
present
tabl
bacteri
analysi
respiratori
tract
carri
especi
calcul
score
type
sampl
bronchoalveolar
lavag
blind
distal
sampl
tracheal
aspir
left
discret
attend
physician
depend
procedur
unit
patient
suspect
develop
vap
two
assessor
mask
group
assign
review
casereport
form
classifi
case
accord
accept
definit
patient
monitor
randomis
discharg
icu
without
exceed
day
follow
inclus
evalu
assess
criteria
carri
depend
durat
patient
stay
icu
evalu
carri
discharg
icu
patient
icu
stay
day
evalu
carri
day
discharg
icu
patient
icu
stay
day
evalu
carri
day
patient
icu
stay
day
patient
leav
icu
consid
exit
studi
readmiss
icu
even
within
day
follow
trauma
taken
account
event
occur
first
box
american
thorac
societi
definit
vap
vap
diagnosi
base
associ
hour
start
mechan
ventil
least
two
clinic
sign
among
follow
fever
hypothermia
purul
endotrach
aspir
hyperleucocytosi
leucopenia
one
radiolog
sign
new
radiograph
condens
modif
previous
exist
radiograph
condens
posit
bacteri
analysi
respiratori
tract
cultur
least
cfuml
brush
fibroscopi
blind
protect
distal
sampl
cfuml
bronchoalveolar
lavag
cfuml
tracheal
aspir
cfu
colonyform
unit
vap
ventilatorassoci
pneumonia
tabl
center
diseas
control
modifi
definit
ventilatorassoci
event
new
respiratori
deterior
ventilatorassoci
condit
vac
calendar
day
stabl
decreas
daili
minimum
posit
endexpiratori
pressur
daili
minimum
fraction
inspir
oxygen
follow
rise
daili
minimum
posit
endexpiratori
pressur
cm
water
rise
daili
minimum
percentag
inspir
oxygen
point
sustain
calendar
day
open
access
icu
discharg
consid
assess
criteria
patient
exit
studi
wish
without
provid
justif
qualiti
care
alter
outcom
taken
account
final
analysi
sampl
size
calcul
number
particip
group
base
estim
vap
incid
patient
control
group
reduc
vap
incid
halv
intervent
group
studi
power
p
valu
bilater
situat
vap
incid
control
group
chosen
basi
unpublish
analysi
databas
french
research
network
devot
studi
trauma
patient
given
recruit
potenti
centr
approach
particip
studi
togeth
constraint
associ
protocol
expect
inclus
durat
set
month
recruit
patient
admit
icu
french
univers
hospit
screen
enrol
within
hour
trauma
patient
enrol
decid
attend
physician
computergener
number
list
provid
statistician
involv
either
screen
patient
assess
outcom
randomis
carri
use
secur
webbas
randomis
system
stratif
centr
sever
unconsci
time
inclus
glasgow
coma
scale
account
differ
patient
treatment
centr
heighten
vap
risk
patient
glasgow
coma
scale
patient
randomli
assign
one
two
treatment
group
base
method
use
monitor
tracheal
cuff
pressur
mask
particip
icu
staff
feasibl
due
natur
devic
place
close
patient
face
howev
microbiologist
test
pulmonari
blood
sampl
outcom
assessor
nm
om
statistician
mask
group
assign
data
collect
confidenti
storag
archiv
studi
document
independ
clinic
research
assist
avail
particip
hospit
help
run
studi
data
collect
studi
document
deidentifi
store
year
per
protocol
nonclin
trial
notif
ctn
intervent
studi
data
electron
store
doubl
passwordprotect
comput
hard
copi
data
clinic
research
file
store
lock
secur
offic
personnel
involv
data
analysi
mask
princip
investig
statistician
access
final
data
set
statist
method
analys
perform
follow
intentiontotreat
principl
randomis
patient
except
withdrew
consent
statist
analys
take
account
stratifi
randomis
centr
glasgow
coma
scale
recommend
consolid
standard
report
trial
consort
guidelin
studi
report
literatur
categor
variabl
report
number
percentag
continu
variabl
summaris
use
mean
median
iqr
normal
nonnorm
distribut
data
along
respect
ci
analys
primari
end
point
secondari
end
point
relat
vap
incid
use
logist
regress
model
adjust
stratif
factor
covari
significantli
imbalanc
group
cumul
event
curv
time
first
vap
diagnosi
estim
use
kaplanmei
procedur
number
ventilatorfre
day
vfd
number
day
patient
success
wean
mechan
ventil
end
point
day
day
defin
follow
patient
die
within
day
requir
mechan
open
access
ventil
day
vfd
patient
success
wean
mechan
ventil
within
day
x
number
day
mechan
ventil
number
antibioticfre
day
afd
number
day
live
patient
receiv
antibiot
day
prophylact
cur
antibiot
therapi
relat
trauma
consid
vfd
afd
assess
manner
compar
group
use
regress
model
allow
adjust
stratif
factor
categor
secondari
end
point
compar
group
use
logist
regress
model
statist
analys
conduct
use
sa
softwar
miss
data
describ
number
correspond
percentag
group
presenc
imbal
proport
miss
data
treatment
group
evalu
use
logist
regress
model
assess
robust
result
case
miss
data
sensit
analys
perform
imput
miss
data
worst
valu
failur
death
etc
multipl
imput
clinic
research
associ
ensur
patient
inclus
data
collect
registri
rapport
line
protocol
studi
conduct
accord
good
clinic
practic
guidelin
furthermor
verifi
follow
variabl
patient
initi
date
birth
sex
sign
consent
form
elig
criteria
date
randomis
treatment
assign
advers
event
studi
end
point
prior
consent
subject
possibl
therefor
consent
subject
legal
accept
repres
request
consent
form
specif
design
subject
legal
accept
repres
provid
document
approv
favour
opinion
institut
review
board
order
protect
right
safeti
wellb
subject
ensur
complianc
applic
regulatori
requir
nonobject
particip
studi
patient
rel
solicit
accord
requir
ethic
committe
peopl
direct
access
data
take
necessari
precaut
maintain
confidenti
data
collect
studi
render
anonym
initi
inclus
number
regist
result
studi
releas
particip
physician
refer
physician
medic
commun
later
year
complet
trial
present
scientif
confer
public
peerreview
journal
discuss
best
knowledg
first
largescal
studi
evalu
use
continu
pneumat
regul
tracheal
cuff
pressur
popul
sever
trauma
patient
also
benefit
recommend
vap
prevent
measur
individu
level
benefit
expect
includ
reduc
durat
mechan
ventil
stay
icu
well
improv
patient
prognosi
collect
level
lower
cost
hospit
stay
expect
addit
fewer
day
antibiot
associ
reduct
select
pressur
perpetu
multidrugresist
bacteria
order
keep
manag
practic
standardis
possibl
decid
limit
number
investig
centr
univers
hospit
centr
chu
recognis
field
trauma
care
treat
sever
trauma
patient
per
year
centr
belong
three
network
share
common
object
promot
multicentr
clinic
research
consist
grand
ouest
surgic
intens
care
network
grand
sud
intens
care
network
traumabas
aphp
trauma
intens
care
network
centr
also
share
standard
care
previou
studi
evalu
devic
aim
continu
regul
tracheal
cuff
pressur
report
devic
effici
control
cuff
pressur
welltoler
patient
set
choic
pneumat
devic
instead
electron
devic
present
sever
advantag
better
reactiv
fewer
period
insuffici
excess
pressur
tracheal
cuff
consequ
reduc
risk
microinhal
tracheal
lesion
need
electr
suppli
low
acquisit
cost
eas
use
final
encourag
preliminari
result
previous
report
use
devic
also
significantli
contribut
choic
open
access
present
studi
addit
risk
incur
studi
particip
term
usual
therapi
receiv
hospit
stay
patient
care
usual
attend
physician
supplementari
examin
impos
protocol
patient
unabl
hear
given
inform
inform
regard
studi
deliv
close
rel
friend
accord
direct
french
nation
commiss
data
protect
liberti
patient
afford
possibl
object
use
data
gather
name
incid
vap
primari
end
point
trial
howev
vap
diagnosi
may
difficult
perform
icu
sever
criteria
propos
report
perform
poor
trial
vap
incid
determin
accord
at
criteria
choic
could
challeng
howev
criteria
commonli
use
vap
diagnosi
literatur
also
record
vae
accord
cdc
criteria
compar
at
cdc
definit
vap
secondari
object
halv
vap
rate
could
seem
ambiti
singl
intervent
howev
find
report
two
previou
studi
assess
clinic
impact
continu
control
devic
cuff
pressur
mouth
care
stress
ulcer
prophylaxi
base
local
written
protocol
may
act
potenti
confound
variabl
howev
control
stratif
randomis
centr
level
adjust
statist
analys
case
differ
group
final
mask
feasibl
due
natur
intervent
howev
end
point
assess
two
assessor
mask
group
assign
order
minimis
bia
conclus
trial
first
multicentr
randomis
control
openlabel
studi
adequ
power
test
hypothesi
continu
pneumat
regul
tracheal
cuff
pressur
prevent
vap
mechan
ventil
sever
trauma
patient
